Introduction
Throughout pregnancy, it is typical for a patient to undergo changes in various organ systems, such as cardiovascular, respiratory, gastrointestinal, urinary, and more, in response to a growing fetus. Factors that lead to changes in these organ systems include, but are not limited to, changes in hormone levels, fetus size, and the physiologic requirements of the gravida and fetus, with the majority of physiologic changes returning to normal in the postpartum period. It should be noted that many of these changes are more pronounced in multiparous patients. This topic discusses the various physiologic changes in the gravida associated with each organ system and the clinical significance of these changes.
Organ Systems Involved
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Organ Systems Involved
Endocrine
Many of the physiologic changes associated with pregnancy can be attributed to changes in hormones produced by the placenta. One such hormone is human chorionic gonadotropin (hCG), specifically, the beta subunit (beta-hCG). Beta-hCG is produced by the syncytiotrophoblastic cells of the placenta and is responsible for stimulating the corpus luteum to produce progesterone, which is essential in maintaining pregnancy.[1] Beta-hCG stimulates and maintains the corpus luteum, preventing further ovulation. In addition, beta-hCG is responsible for stimulating the ovaries to produce elevated levels of estrogen and progesterone until the end of the first trimester (approximately weeks 10-12), at which time the placenta is mature enough to take over the production of estrogen and progesterone.[2]
In a nonpregnant individual, the hypothalamus produces and releases thyrotropin-releasing hormone, which stimulates the release of thyroid-stimulating hormone and prolactin from the anterior pituitary. In a pregnant individual, the placenta releases additional thyrotropin-releasing hormone, which leads to the further release of thyroid-stimulating hormone and prolactin. Thyroid hormone production increases by about 50% during pregnancy but free T3 and free T4 remain unchanged due to the simultaneous increase in thyroid-binding globulin.[3] These additional thyroid hormones are necessary for appropriate brain development and thyroid function of the growing fetus.[4] During pregnancy, the pituitary gland enlarges by approximately 135% due to lactotroph hyperplasia, further increasing circulating prolactin levels.[5] Prolactin levels increase 10-fold throughout pregnancy, allowing breast tissue development and milk production.[6]
Relaxin is a peptide hormone released by the corpus luteum in both pregnant and nonpregnant individuals and by the placenta and decidua in pregnant individuals. This hormone allows for connective tissue remodeling and subsequent softening of the birth canal, mammary gland growth and differentiation, and inhibition of uterine contractile activity.[7] Relaxin also mediates nitric oxide release, allowing systemic vasodilation and decreasing blood pressure during pregnancy.[8] Free cortisol levels are about 2.5 times higher in the pregnant versus nonpregnant state.[9] This increase in cortisol levels is essential for the normal development of the fetal brain. However, excess maternal levels of glucocorticoids can be neurotoxic to the fetus, resulting in impaired neural development.[10] Endorphins and enkephalin concentrations also increase in pregnancy, leading to an elevated pain threshold to counteract the pain due to labor.[11]
Cardiovascular
The cardiovascular system of a pregnant individual undergo significant physiologic changes, including an increased heart rate, stroke volume, cardiac output, and a decrease in vascular resistance.[12] Increased ventricular wall mass, myocardial contractility, and cardiac compliance are also seen. Within the first trimester, vasodilatory effects of nitric oxide, prostaglandins, and progesterone occur, leading to peripheral vasodilation, which, by 8 weeks of gestation, leads to a 20% increase in cardiac output. Additionally, peripheral vasodilation leads to a fall in systemic vascular resistance, compensated for by an increase in cardiac output of approximately 40% throughout pregnancy. Peripheral vasodilation also leads to a decrease in blood pressure early in pregnancy, with blood pressure reaching its lowest point at about 20-24 weeks gestation leading to physiologic hypotension.
Cardiac output is the product of heart rate and stroke volume. The increase in cardiac output is mainly due to increased stroke volume and, to a lesser extent, an increase in heart rate.[13] This increase in cardiac output directs blood toward the uterus, placenta, kidneys, skin, and extremities. Cutaneous and extremity blood flow raises maternal skin temperature and is a mechanism of maternal thermoregulation. Cardiac output increases by 75% following delivery due to inferior vena cava compression relief.[14]
While early in pregnancy, the stroke volume is responsible for maintaining the elevated cardiac output, during the third trimester, it is an increase in heart rate that becomes responsible for maintaining an increase in cardiac output. Increased cardiac output is needed later in pregnancy, as uterine blood flow increases 10-fold and renal blood flow increases 50%. There are minimal alterations in blood flow to the liver and brain. During active labor, uterine contractions cause "auto-transfusion" of approximately 500 mL of blood back into the maternal circulation.
Over 90% of pregnant patients develop a systolic murmur in pregnancy that disappear following delivery, and 18% of pregnant patients develop a diastolic murmur. A third heart sound is common in pregnancy, occurring in over 80% of pregnant individuals, with a fourth heart sound occurring in approximately 16% of pregnant individuals.[15] Normal ECG findings in pregnancy may include small Q waves and inverted T waves in lead III, ST-segment depression and T-wave inversion in the lateral and inferior leads, and left-axis shift of the QRS complex.[13]
Respiratory
Functional residual capacity is the sum of expiratory reserve volume and residual volume. Throughout pregnancy, due to the enlarging uterus, the resting position of the diaphragm shifts up approximately 5 cm, leading to bibasilar alveolar collapse and basilar atelectasis, thus decreasing the expiratory reserve volume and functional residual capacity. Vital capacity remains unchanged, as reduced expiratory reserve volume is accompanied by an increased inspiratory reserve volume. Increased progesterone concentrations, beginning in the first trimester, cause an increase in tidal volume by approximately 30-50%. The product of tidal volume and respiratory rate is minute ventilation, which increase by 30-50%. The respiratory rate remains unchanged from the nonpregnant state.
Progesterone stimulates respiration and can lead to hyperventilation (exhaling more than inhaling). Due to this, the arterial partial pressure of oxygen (PaO2) increases to 105 mmHg, while the arterial partial pressure of carbon dioxide (PaCO2) decreases to approximately 30 mmHg.[16] This blood gas change results in slight respiratory alkalosis metabolically compensated by increased bicarbonate excretion by the kidneys to approximately 20 mEq/L.[17] The oxyhemoglobin dissociation curve is shifted to the right, favoring oxygen dissociation and facilitating oxygen transfer across the placenta.
During labor, minute ventilation increases by as much as 140-200% depending on the stage of labor, leading to an even more pronounced decrease in PaCO2.[18] Metabolic oxygen consumption rises during childbirth due to uterine contractions, sympathetic activity, and maternal Valsalva maneuvers to deliver the fetus. As oxygen demand outpaces oxygen delivery during active labor, anaerobic metabolism ensues, and lactic acid production occurs.[19]
Hematologic
In a pregnant individual, plasma renin levels rise, and atrial natriuretic peptide levels tend to fall, leading to systemic vasodilation and increased vascular capacitance. This physiologic process, without compensation, would lead to an underfilled vascular system. The maternal blood volume is increased by approximately 1.5 liters to compensate for this and blood loss during delivery. In addition, maternal erythropoietin production is increased, increasing red blood cell (RBC) mass by approximately 30%. This increase in plasma volume greater than RBC mass results in dilutional anemia, or physiologic anemia of pregnancy.[20]
An increase in RBC mass, coupled with increased blood flow to the uterus, leads to optimized oxygen transport to the fetus. However, an increase in RBC mass also means an increase in the physiologic demand for iron throughout pregnancy. Approximately 1,000 mg (1 gram) of iron is needed during pregnancy, two-thirds for needs of the gravida and one-third for placental-fetal tissue growth and needs. Less iron is required in the first trimester (0.8 mg/day), with more daily iron necessary for the third trimester (3.0-7.5 mg/day).[21]
Pregnancy is a hypercoagulable (prothrombotic) state, with increased levels of coagulation factors caused by elevated estrogen levels mediating an increase in protein synthesis. As the pregnancy progresses, clotting factors VII, VIII, X, XII, vWF, and fibrinogen levels markedly increase. Due to the increase in factor VIII, activated partial thromboplastin time is typically shortened, while prothrombin time and thrombin time remain unchanged.[20] Due to this hypercoagulable state, pregnant individuals are up to 5 times more likely to develop a deep vein thrombosis than their nonpregnant counterparts.[22]
Renal
As previously mentioned, increased cardiac output leads to increased blood flow to the kidneys, increased glomerular filtration rate by about 50%, and increased renal plasma flow by as much as 80%. This increased glomerular filtration rate leads to a subsequent decrease in the serum concentration of creatinine, urea, and uric acid. Due to fluid retention, the kidneys enlarge, and physiologic hydronephrosis occurs. Due to the actions of progesterone and relaxin on smooth muscles, dilation of the urinary collecting system occurs, which can lead to urinary stasis and a 40% increase in the predisposition for urinary tract infections and pyelonephritis with asymptomatic bacteriuria in pregnancy.[23] The renin-angiotensin-aldosterone system upregulation typically occurs in a normal pregnancy. Estrogen produced by the placenta increases the synthesis of angiotensinogen by the liver, which leads to an increase in angiotensin II. Renin is released from the ovaries and decidua of the uterus. At approximately 8 weeks of gestation, aldosterone levels rise and continue to increase 3-6x the upper limit of normal in the third trimester. The result is a net gain of approximately 1.5 liters of water (as previously mentioned).[23]
Gastrointestinal
Gastroesophageal reflux disease is common in pregnant patients due to multiple factors. Increased pregnancy progesterone leads to reduced lower esophageal sphincter resting muscle tone, delayed gastric emptying, and increased small bowel transit time. These findings, in addition to compression from a gravid uterus, predispose to gastroesophageal reflux disease.[24]
Integumentary
During pregnancy, elevated hormone levels such as estrogen or progesterone can stimulate excess melanin production, leading to hyperpigmentation of the face, known as melasma. Linea nigra, a hyperpigmented line running down the center of the abdomen, may also occur due to pregnancy-related hyperpigmentation and is typically associated with increased pigmentation of the areolae, axillae, and genitals.[25]
Clinical Significance
Medication use is common in pregnancy, with multiple studies showing that 75-97% of pregnant individuals take at least 1 over-the-counter medication during their pregnancy.[26][27] This statistic is important for physicians and pharmacists to remember, as many maternal changes in pregnancy can affect certain medications' pharmacodynamic and pharmacokinetic (absorption, distribution, metabolism, and elimination) properties. Failure to consider the maternal physiologic adaptations during pregnancy can lead to maternal morbidity due to over or under-treating the pregnant individual. The increase in renal clearance during pregnancy can increase the elimination of renally cleared medications. For example, lithium, a medication used to treat bipolar disorder, is renally cleared. Lithium clearance is doubled during the third trimester of pregnancy, leading to sub-therapeutic levels.[28] Additional renally cleared medications to remember are ampicillin, cefazolin, cefuroxime, piperacillin, digoxin, and atenolol, among others.[29]
As soon as pregnancy is confirmed, hypothyroid patients requiring levothyroxine should increase their dose by 30%, and serum thyrotropin levels should be closely monitored.[30] Additionally, physiologic hypotension of pregnancy is essential to understand when dealing with pregnant patients who are already hypertensive and taking hypertension medication. Whether family medicine, cardiology, or obstetric anesthesia, clinicians in every medical specialty should understand the physiologic changes pregnant individuals undergo and adapt accordingly within their practice and care of that patient.
References
Betz D, Fane K. Human Chorionic Gonadotropin. StatPearls. 2024 Jan:(): [PubMed PMID: 30422545]
Kumar P, Magon N. Hormones in pregnancy. Nigerian medical journal : journal of the Nigeria Medical Association. 2012 Oct:53(4):179-83. doi: 10.4103/0300-1652.107549. Epub [PubMed PMID: 23661874]
Harada A, Hershman JM, Reed AW, Braunstein GD, Dignam WJ, Derzko C, Friedman S, Jewelewicz R, Pekary AE. Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. The Journal of clinical endocrinology and metabolism. 1979 May:48(5):793-7 [PubMed PMID: 429524]
Napso T,Yong HEJ,Lopez-Tello J,Sferruzzi-Perri AN, The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation. Frontiers in physiology. 2018 [PubMed PMID: 30174608]
Chourpiliadi C, Paparodis R. Physiology, Pituitary Issues During Pregnancy. StatPearls. 2024 Jan:(): [PubMed PMID: 31869188]
Al-Chalabi M, Bass AN, Alsalman I. Physiology, Prolactin. StatPearls. 2024 Jan:(): [PubMed PMID: 29939606]
Bani D. Relaxin: a pleiotropic hormone. General pharmacology. 1997 Jan:28(1):13-22 [PubMed PMID: 9112071]
Level 3 (low-level) evidenceConrad KP. Maternal vasodilation in pregnancy: the emerging role of relaxin. American journal of physiology. Regulatory, integrative and comparative physiology. 2011 Aug:301(2):R267-75. doi: 10.1152/ajpregu.00156.2011. Epub 2011 May 25 [PubMed PMID: 21613576]
Level 3 (low-level) evidenceRosenthal HE, Slaunwhite WR Jr, Sandberg AA. Transcortin: a corticosteroid-binding protein of plasma. X. Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy. The Journal of clinical endocrinology and metabolism. 1969 Mar:29(3):352-67 [PubMed PMID: 5812975]
Kapoor A, Dunn E, Kostaki A, Andrews MH, Matthews SG. Fetal programming of hypothalamo-pituitary-adrenal function: prenatal stress and glucocorticoids. The Journal of physiology. 2006 Apr 1:572(Pt 1):31-44 [PubMed PMID: 16469780]
Level 3 (low-level) evidenceAbboud TK, Sarkis F, Hung TT, Khoo SS, Varakian L, Henriksen E, Noueihed R, Goebelsmann U. Effects of epidural anesthesia during labor on maternal plasma beta-endorphin levels. Anesthesiology. 1983 Jul:59(1):1-5 [PubMed PMID: 6305238]
Klein HH, Pich S. [Cardiovascular changes during pregnancy]. Herz. 2003 May:28(3):173-4 [PubMed PMID: 12756474]
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovascular journal of Africa. 2016 Mar-Apr:27(2):89-94. doi: 10.5830/CVJA-2016-021. Epub [PubMed PMID: 27213856]
Lee W, Rokey R, Miller J, Cotton DB. Maternal hemodynamic effects of uterine contractions by M-mode and pulsed-Doppler echocardiography. American journal of obstetrics and gynecology. 1989 Oct:161(4):974-7 [PubMed PMID: 2801847]
Breuer HW. [Auscultation of the heart in pregnancy (author's transl)]. MMW, Munchener medizinische Wochenschrift. 1981 Nov 6:123(45):1705-7 [PubMed PMID: 6795485]
Shankar KB, Moseley H, Vemula V, Ramasamy M, Kumar Y. Arterial to end-tidal carbon dioxide tension difference during anaesthesia in early pregnancy. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1989 Mar:36(2):124-7 [PubMed PMID: 2495859]
Dayal P, Murata Y, Takamura H. Antepartum and postpartum acid-base changes in maternal blood in normal and complicated pregnancies. The Journal of obstetrics and gynaecology of the British Commonwealth. 1972 Jul:79(7):612-24 [PubMed PMID: 5043425]
Hägerdal M, Morgan CW, Sumner AE, Gutsche BB. Minute ventilation and oxygen consumption during labor with epidural analgesia. Anesthesiology. 1983 Nov:59(5):425-7 [PubMed PMID: 6638550]
Jouppila R, Hollmén A. The effect of segmental epidural analgesia on maternal and foetal acid-base balance, lactate, serum potassium and creatine phosphokinase during labour. Acta anaesthesiologica Scandinavica. 1976:20(3):259-68 [PubMed PMID: 961334]
Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 2012 Sep:28(3):144-6. doi: 10.1007/s12288-012-0175-6. Epub 2012 Jul 15 [PubMed PMID: 23997449]
Brannon PM, Taylor CL. Iron Supplementation during Pregnancy and Infancy: Uncertainties and Implications for Research and Policy. Nutrients. 2017 Dec 6:9(12):. doi: 10.3390/nu9121327. Epub 2017 Dec 6 [PubMed PMID: 29210994]
Devis P, Knuttinen MG. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovascular diagnosis and therapy. 2017 Dec:7(Suppl 3):S309-S319. doi: 10.21037/cdt.2017.10.08. Epub [PubMed PMID: 29399535]
Cheung KL, Lafayette RA. Renal physiology of pregnancy. Advances in chronic kidney disease. 2013 May:20(3):209-14. doi: 10.1053/j.ackd.2013.01.012. Epub [PubMed PMID: 23928384]
Level 3 (low-level) evidenceEverson GT. Gastrointestinal motility in pregnancy. Gastroenterology clinics of North America. 1992 Dec:21(4):751-76 [PubMed PMID: 1478733]
Bieber AK, Martires KJ, Stein JA, Grant-Kels JM, Driscoll MS, Pomeranz MK. Pigmentation and Pregnancy: Knowing What Is Normal. Obstetrics and gynecology. 2017 Jan:129(1):168-173. doi: 10.1097/AOG.0000000000001806. Epub [PubMed PMID: 27926637]
Haas DM, Marsh DJ, Dang DT, Parker CB, Wing DA, Simhan HN, Grobman WA, Mercer BM, Silver RM, Hoffman MK, Parry S, Iams JD, Caritis SN, Wapner RJ, Esplin MS, Elovitz MA, Peaceman AM, Chung J, Saade GR, Reddy UM. Prescription and Other Medication Use in Pregnancy. Obstetrics and gynecology. 2018 May:131(5):789-798. doi: 10.1097/AOG.0000000000002579. Epub [PubMed PMID: 29630018]
Bérard A, Abbas-Chorfa F, Kassai B, Vial T, Nguyen KA, Sheehy O, Schott AM. The French Pregnancy Cohort: Medication use during pregnancy in the French population. PloS one. 2019:14(7):e0219095. doi: 10.1371/journal.pone.0219095. Epub 2019 Jul 17 [PubMed PMID: 31314794]
Costantine MM. Physiologic and pharmacokinetic changes in pregnancy. Frontiers in pharmacology. 2014:5():65. doi: 10.3389/fphar.2014.00065. Epub 2014 Apr 3 [PubMed PMID: 24772083]
Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clinical pharmacokinetics. 2005:44(10):989-1008 [PubMed PMID: 16176115]
Level 3 (low-level) evidenceAlexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. The New England journal of medicine. 2004 Jul 15:351(3):241-9 [PubMed PMID: 15254282]